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Abstract
Nonadherence to psychotropic medications among patients with serious and persistent
psychiatric disorders, including bipolar disorder and schizophrenia, is approximately
70%. Nonadherence is a common barrier to the treatment of individuals with mental
health disorders. However, there is limited awareness of evidence-based interventions
and strategies to address this problem. Therefore, the question for this project asks
whether a systematic review can identify strategies to improve adherence of psychotropic
medications among individuals with serious and persistent mental illness. The purpose of
this systematic review was to explore the evidence-based strategies that can aid in
increasing medication adherence in patients with mental health disease. Sources of
evidence included online databases such as Walden University Library, PubMed,
Cochrane Collaboration, PsychINFO, ProQuest, EBSCOHost, Google Scholar, and
Joanna Briggs Institute. The health belief model provided foundation for this project by
supporting awareness and self-efficacy of medication adherence. Preferred Reporting
Items for Systematic Reviews and Meta-Analyses was used to analyze the evidence.
Findings revealed that a healthcare staff collaborated education approach targeted toward
the patient or to the patient and family members was the most effective strategy to
support medication adherence. Other evidence-based interventions such as home-based
physical exercise programs, cognitive-behavioral and motivational strategies, blister
packaging, financial incentives, and cost sharing were also found to improve adherence.
This systematic review elicits positive social change in practice by facilitating adherence
to psychotropic medications; thus, reducing hospitalization and comorbidity.
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Section 1: Nature of the Project
Introduction
Medication nonadherence is a significant challenge for psychiatric clinicians because it
increases the possibility of complications and readmissions, thus, increasing healthcare
expenditure for patients with serious and persistent mental illness (SPMI; Cutler et al., 2018).
Nonadherence to psychotropic medications takes place at the initial, implementation, and
persistent stages of clinical therapy for this population (Torres-Robles et al., 2018). The Centers
for Disease Control and Prevention (CDC) has also identified medication nonadherence as a
global problem, especially in long-term therapies (Neiman et al., 2017). Nonadherence to
psychotropic medications has also been associated with various adverse outcomes, including
suicidal tendencies, deterioration of prognosis, and lower quality of life among psychiatric
patients (Cutler et al., 2018). For example, nonadherence is linked to mortality, violence, and
hospital readmission among patients with schizophrenia (Steinkamp et al., 2019; Torres-Robles
et al., 2018).
Medication nonadherence among individuals with mood disorders such as bipolar
disorder and major depressive disorder has also been linked with slower initial recovery, high
suicide risk, and hospitalizations (Jawad, Watson, Haddad, Talbot, & McAllister-Williams,
2018; Steinkamp et al., 2019). These studies highlight the importance of medication adherence
across various mental health disorders.
The advent of more effective psychotropic medications has ushered in an era in the
management and treatment of SPMI, improving the ability of many patients to live
independently (Montejo, Montejo, & Baldwin, 2018). However, to attain maximum benefit,
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patients with mental health disorders have to take all medications and therapies as prescribed by
their clinicians (Montejo et al., 2018). Studies have indicated that nonadherence to psychotropic
medications can result from socioeconomic-, treatment, condition, patient, and health systemrelated factors (Cutler et al., 2018; Semahegn et al., 2018; Steinkamp et al., 2019; Torres-Robles
et al., 2018). Mental health disorders pose significant challenges for patients, making it difficult
to adhere to prescribed medications (Cutler et al., 2018).
In this systematic review, I sought to identify evidence-based strategies that are employed
to improve medication adherence among patients with SPMI. This project has the potential to
identify positive social changes in practice that could increase adherence to psychotropic
medication therapies, improving quality of life, and decreasing hospitalization.
Problem Statement
Despite the ability of psychotropic medications to minimize the severity of mental health
disorders, many patients still abandon prescribed medications prematurely (Montejo et al., 2018).
The prevalence of medication nonadherence among mental health patients is considerably high
and varies based on disorders (Semahegn et al., 2018). For patients with schizophrenia,
nonadherence rates range from 41-50%, while for those with depression, it is between 13% and
52% (Steinkamp et al., 2019). Also, individuals with opioid dependence and anxiety disorders
have nonadherence rates of 68% and 57%, respectively (Steinkamp et al., 2019). According to
Chakrabarti (2016), the rate of medication nonadherence among patients with mental health
conditions could reach 70%. These statistics provide a glimpse of how severely the problem of
nonadherence affects psychiatric clinicians in the United States.
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In the United States, hospitalizations resulting from medication nonadherence cost over
$100 billion every year (Shafrin et al., 2017). In addition, the annual cost of nonadherence to
psychotropic medications among patients with mental health illnesses is approximately $1.5
billion (Shafrin et al., 2017). A recent study by Cutler et al. (2018) also indicated that the
estimated cost of nonadherence to psychotropic medication is $3,252-$19,363 for every patient.
Given that about 46.6 million adults in the United States are affected by mental health disorders
annually, there is a need for more effective interventions to improve medication adherence in this
population (Substance Abuse and Mental Health Services Administration [SAHMSA], 2017).
These figures highlight the extent of nonadherence to prescribed treatment regimen aimed at
managing psychotic symptoms among patients with SPMI.
According to Harrison, Kats, Williams, and Aziz-Zadeh (2019), persistence or
maintaining adherence to psychotropic medications is difficult, and the nonadherence rate
worsens over time. Nonadherence to psychotropic medications is a significant challenge because
it increases the patients’ risk of readmission, suicide, and deterioration, and reduces their quality
of life (Borba et al., 2018). Research has indicated that nonadherence can also affect the patients’
health negatively; thus, increasing the overall healthcare costs for managing mental health
disorders (Cutler et al., 2018; Joe & Lee, 2016). In addition, some patients with SPMI lack
adequate support and access to medications, and others have a misconception about the
effectiveness of antipsychotics, which increases the likelihood of nonadherence (El-Mallakh &
Findlay, 2015). Therefore, there is a need for psychiatric facilities to adopt new and more
effective strategies for promoting adherence to psychotropic medications.
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Over the past few decades, health practitioners have been trying to address the problem
of medication nonadherence by designing various educational, therapeutic, technological, and
pharmacological interventions (Martin, Feig, Maksoudian, Wysong, & Faasse, 2018). An
increase in awareness of the most effective strategies for improving adherence to psychotropic
medications can be applied in practice to improve patient outcomes (Jawad et al., 2018).
Reducing nonadherence can reduce morbidity and minimize the cost of care for mental health
patients, thus decreasing the burden for families and psychiatric facilities (Cutler et al., 2018; Joe
& Lee, 2016; Rao, George, Sudarshan, & Begum, 2017)
Purpose
The purpose of this systematic review was to explore the evidence-based strategies that
can aid in increasing medication adherence in mentally ill patients. The guiding practice-focused
question was, “What evidence-based strategies can be implemented by healthcare providers to
improve adherence to antipsychotics among individuals with SPMI?” There is a gap in the
literature regarding evidence on the improvement of medication adherence among patients with
mental health disorders (Kleinsinger, 2018). The project has the potential to address the gap-inpractice relating to the most effective strategies and interventions for improving adherence to
antipsychotics among individuals with SPMI. The systematic review facilitated the synthesis of
relevant evidence regarding the most effective strategies for improving medication adherence
among patients with SPMI.
Nature of the Doctoral Project
For this project, I employed a systematic review design to explore the most recent and
relevant literature on evidence-based strategies for increasing medication adherence among
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patients with SPMI. The rationale behind the use of a systematic review design is because of its
principles of replicability, rigor, and transparency that increase the strength and quality of
evidence (Booth, 2016).
Viswanathan et al. (2018) indicated that systematic reviews are reliable because they
facilitate broader research while maintaining focus on empirical evidence as opposed to
preconceived knowledge of a given problem. A primary advantage of systematic reviews is that
they help in reducing implicit researcher bias by employing broad literature search strategies,
uniform inclusion-exclusion criteria, and predefined search terms (Booth, 2016). Additionally,
systematic reviews facilitate the careful evaluation of research problems and questions from the
onset, including the analysis of interventions, populations, associated comparisons, and findings
(Sturm & Sunyaev, 2019). The focus improves the investigators’ likelihood of addressing the
research questions more objectively and clearly (Viswanathan et al., 2018).
The primary sources of evidence included peer-reviewed studies on evidence-based
strategies for improving medication adherence among patients with SPMI. The studies were
obtained through a comprehensive literature search on reliable online databases, including
Walden University Library, Cochrane Collaboration, PubMed, PsychINFO, EBSCOHost,
ProQuest, Google Scholar, and Joanna Briggs Institute.
Systematic reviews have various benefits over traditional literature reviews. For example,
the investigators’ increased focus is an advantage over traditional literature reviews, which are
based on results from previous research without consideration of the study design, analytical
methods, data collection, sample size, and data (Sturm & Sunyaev, 2019). In addition, systematic
reviews focus on validity, impact, and strength of evidence (Sturm & Sunyaev, 2019).
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Synthesizing information on the research designs, causality, and analytical methods used in the
selected studies allowed the DNP student to evaluate the robustness and reliability of the
collected evidence (Booth, 2016). Systematic reviews are also more reliable compared to
traditional literature reviews because they follow a clear protocol that guides the investigator
throughout the project and improves transparency (Munn et al., 2018).
However, the systematic review design also has several limitations that could influence
the quality of the findings (Munn et al., 2018). For example, systematic reviews are sophisticated
and require access to several databases and peer-reviewed studies, which can be challenging and
expensive for students (Sturm & Sunyaev, 2019). Another potential limitation of systematic
reviews is that literature searches on institutional databases can undermine the objectivity and
introduce bias (Munn et al., 2018). As indicated by Viswanathan et al. (2018), the search strings
in different databases can be discarded or adapted altogether because the websites are designed
using specific search functions. As a result, investigators can miss a potentially large number of
relevant studies.
The inclusion-exclusion criteria of systematic reviews may also introduce bias during
screening and may result in research team members having different interpretations (Sturm &
Sunyaev, 2019). According to Munn et al. (2018), systematic reviews have a high likelihood of
subjectivity when screening studies and when a large project team is involved. Because every
team member interprets the inclusion-exclusion criteria differently, there is a high likelihood of
subjectivity that may negatively influence the findings (Sturm & Sunyaev, 2019). In addition,
systematic reviews are affected by resource and time constraints, which can be another source of
bias (Viswanathan et al., 2018). The systematic review was aimed at addressing the gap in
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research on effective evidence-based strategies for improving adherence among patients with
SPMI. It was anticipated that the findings of this systematic review would improve the
understanding of evidence-based practices for improving adherence to psychotropic medication
among SPMI patients and improve their health outcomes.
Significance of the Project
Nonadherence to psychotropic medications is a significant public health problem in the
United States. Recent studies have associated nonadherence to psychotropic medications with
increased recidivism and emergency department visits, higher costs of care, and higher mortality
rates among individuals with mental health disorders (Cutler et al., 2018; Goldstone et al., 2015;
Joe & Lee, 2016). Adherence to psychotropic medication is an essential concern, especially for
patients with severe mental health issues, including bipolar disorder, schizophrenia, and
posttraumatic stress disorder (Penninx & Lange, 2018). Wide variations in nonadherence rates
among individuals with SPMI have been reported over the recent past. For example, Fiszdon,
Kurtz, Choi, Bell, and Martino (2015) found that the adherence rates for schizophrenic
individuals ranged from 25-75%. However, a similar study by Ibrahim, Yahya, Pindar, Wakil,
Garkuwa, and Sale (2015) indicated that the adherence rate for the same population is
approximately 50%.
The significance of the systematic review is based on the need to explore the problem of
medication nonadherence among patients with mental health disorders in the United States.
Recent statistics indicate that clinicians report cases of nonadherence for up to 70% of the mental
health patients (Chakrabarti, 2016). The systematic review improved the understanding of the
evidence-based strategies for promoting adherence among patients with SPMI. The findings of
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this systematic review could significantly influence mental patients’ outcomes if applied in
practice. In addition, the insight provided by the findings of this systematic review could
influence the type of strategies employed by psychiatric clinicians to improve medication
adherence among patients with mental disorders. The systematic review also has the potential to
elicit positive social change in practice by facilitating improvement in adherence to psychotropic
medications; thus, reducing hospitalization and comorbidity. The systematic review could have a
significant influence on all stakeholders in psychiatric care facilities by introducing change in
medication adherence among patients with SPMI. Improved medication adherence would reduce
hospitalizations among patients with mental illnesses such as bipolar disorder and schizophrenia
(Steinkamp et al., 2019). The systematic review would facilitate the synthesis of evidence-based
strategies for improving adherence among patients with SPMI.
The systematic review can facilitate a positive change in practice by enhancing
psychiatric clinicians’ understanding of evidence-based strategies for improving adherence to
psychotropic medications among patients with SPMI. As a result, clinicians can educate patients
and implement the most appropriate interventions to each patient; thus, enhancing patient
outcomes (Borba et al., 2018). The systematic review also has the potential to introduce positive
change in practice by improving adherence to psychotropic medications, hence decreasing the
risk of comorbidities and subsequently reducing healthcare costs for adult individuals with
mental health disorders (Borba et al., 2018). Improved health outcomes among psychiatric
patients would also reduce the rate of rehospitalization and increase the amount of CMS
reimbursements.

9
Summary
Despite the effectiveness of psychotropic medications in reducing the symptoms of
psychiatric disorders, a large proportion of mental health patients still fail to fully comply with
prescribed regimens (Steinkamp et al., 2019). Estimates indicate that nonadherence to
psychotropic medications among individuals with mental health disorders can reach up to 70%,
highlighting the need for effective evidence-based practices to address the problem (Chakrabarti,
2016). The purpose of this systematic review was to explore the evidence-based strategies that
can aid in increasing medication adherence in mentally ill patients.
This section has provided a comprehensive overview of the background of the problem
involving nonadherence to psychiatric medication among adults with SPMI. The guiding
practice-focused question was, “What evidence-based strategies can be implemented by
healthcare providers to improve adherence to antipsychotics among individuals with SPMI?” A
systematic review was conducted to synthesize the most relevant and recent evidence on
strategies for improving adherence to psychotropic medications among adult patients with SPMI.
The benefits of using a systematic review design include enhanced objectivity and transparency,
broader literature search, and minimization of the chance of implicit researcher bias (Ahn &
Kang, 2018). Findings from this systematic review are significant because they can improve
awareness of evidence-based strategies for improving medication adherence among patients with
SPMI. An increase in adherence would improve the patients’ health outcomes, improve their
quality of life, and reduce the healthcare burden of this population on their family and psychiatric
institutions (Jawad et al., 2018). The systematic review also has the potential to effect positive
social change in practice because it could minimize comorbidities and reduce the patients’
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frequency of rehospitalizations. Section 2 presents a comprehensive review of the background
and context of the problem, the Iowa model of evidence-based practice, the relevance of the
systematic review to nursing practice, and the role of the DNP student.
Section 2: Background and Context
Introduction
Nonadherence to psychotropic medications is a serious public health issue in the United
States because of its consequences for the patients, their family members, and the healthcare
sector (Gebeyehu et al., 2019). As a result, various evidence-based interventions have been
adopted to help improve mental health patients’ adherence to prescribed medications (Costa et
al., 2015). The purpose of this systematic review was to explore the evidence-based strategies
that can aid in increasing medication adherence among individuals with SPMI. Despite the
effectiveness of psychotropic medications in reducing the severity of mental health disorders, the
majority of mentally ill patients still fail to optimally adhere to prescribed drugs (Montejo et al.,
2018). The prevalence of medication nonadherence in mentally ill patients is significantly high
despite the implementation of various therapeutic, pharmacological, educational, and
technological interventions by health practitioners (Martin et al., 2018). There is also a lack of
adequate literature on the most effective strategies for improving adherence among individuals
with SPMI. The goal of conducting this systematic review was to address the practice-focused
question, “What evidence-based strategies can be implemented by healthcare providers to
improve adherence to antipsychotics among individuals with SPMI?”
This section involves a discussion of the concepts, models, and theories relevant to the
problem of nonadherence to psychotropic medications among patients with SPMI. Furthermore,
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I describe the relevance of the systematic review of nursing practice and how the findings could
be applied to improve health outcomes among patients with SPMI. Section 2 provides
background of the problem of nonadherence to psychotropic medications in the United States
and explains the role of the DNP student in the systematic review.
Concepts, Models, and Theories
Nonadherence to prescribed psychotropic medications is among the major behavioral risk
factors among individuals with SPMI (Cutler et al., 2018). Nonadherence to psychotropic
medications is usually common among patients with low socioeconomic statuses, minorities, and
those from communities with scarce resources (Torres-Robles et al., 2018). Patients with SPMI
need appropriate and timely behavioral modification and long-term maintenance to avoid
deterioration and adverse complications that may even lead to death (Borba et al., 2018). Thus,
the theoretical foundation of the current systematic review was based on Becker’s (1974) health
belief model (HBM) to help improve the understanding of the importance of adherence to
psychotropic medications among individuals with SPMI.
The HBM
The HBM was developed by psychologists in the 1950s with the goal of improving the
use of preventive programs by the public (Becker, 1974). The model is based on six concepts,
including perceived susceptibility, perceived benefits, perceived usefulness, cues to action,
perceived barriers, and self-efficacy (Jones et al., 2015).
Perceived susceptibility involves people’s beliefs regarding the likelihood of contracting
a disease or condition (Jeihooni, Hidarnia, Kaveh, Hajizadeh, & Askari, 2016). The effectiveness
of any program or initiative aimed at promoting the adherence to psychotropic medications is
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dependent on how individuals perceive the consequences and risk of SPMI in their lives (Jones
et al., 2015). Improving the understanding of evidence-based strategies for increasing medication
adherence in mental healthcare is important among individuals with SPMI as it reduces the risk
of complications and adverse health outcomes. Conducting a systematic review of the evidencebased strategies for improving adherence to psychotropic medications would improve awareness
of the negative health outcomes resulting from the deterioration of patients’ conditions.
Perceived barriers refer to people’s beliefs regarding the psychological and tangible costs
of the interventions or actions (Jones et al., 2015). Thus, the patients’ participation in improving
their behaviors is inhibited by physical, psychosocial, or financial barriers (Jeihooni et al., 2016).
Individuals with SPMI are faced with various barriers in their desire to maintain optimal
adherence to psychotropic medications, including lack of adequate knowledge, health illiteracy,
and financial issues. The systematic review could provide ideas on evidence-based interventions
for improving adherence that is less susceptible to some barriers.
Perceived benefits involve people’s beliefs about the efficacy of the interventions to
minimize the severity of the impacts (Jeihooni et al., 2016). An individual’s perception of
engaging in health-promoting behavior influences the risk of severity and susceptibility (Jones et
al., 2015). To control SPMI and prevent complications resulting from nonadherence, individuals
suffering from these conditions must adopt effective evidence-based interventions. Thus, it is
essential to synthesize high-quality empirical evidence on evidence-based strategies for
improving medication adherence among individuals with SPMI.
Cues to action or triggers to health-related behavioral change are influenced by people’s
ability to act readily (Jones et al., 2015). The cues can result from internal and external sources,
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or both (Jeihooni et al., 2016). I applied this concept in the systematic review to identify
strategies that allow providers to identify and address the causes or triggers of nonadherence
behaviors among mental health patients. A potential strategy could be improving mental health
patients’ knowledge of the importance of adhering to psychotropic medications.
Self-efficacy involves individuals’ confidence in their ability to act towards changing
their health behaviors (Jones et al., 2015). With adequate information on evidence-based
strategies, individuals with SPMI would develop confidence in their ability to maintain and take
their medications as prescribed by psychiatrists (Jeihooni et al., 2016). This systematic review
added to the existing body of literature on evidence-based strategies for improving adherence
among individuals with SPMI. Individuals with SPMI may share information from the
systematic review with others in society. This review may enhance the understanding of different
evidence-based strategies for preventing nonadherence among SPMI patients. For example,
providers would have an increased knowledge of provider-targeted strategies, such as training
and education. Additionally, the systematic review can enhance providers’ experience of patienttargeted strategies such as compliance therapies, cognitive-behavioral therapy, and motivational
interviewing (Kondo et al., 2015).
The HBM is suitable for this systematic review because it provides a foundation for
improving awareness of the importance of adherence to psychotropic medications among
individuals with SPMI. The evidence-based interventions that were the focus of this systematic
review involved strategies for reducing nonadherence to psychotropic medications. The HBM
model also addresses individuals’ belief systems and cultural backgrounds.
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The Iowa Model
Titler et al.’s (2001) Iowa model is mainly used to translate empirical evidence into
practice to improve care quality. The Iowa model is comprised of seven primary steps that
describe the collection of relevant data to provided evidence on a given problem. The Iowa
model can help psychiatric clinicians and other practitioners to apply research findings into
practice to improve patient outcomes.
The first stage of the Iowa model aims to identify a knowledge-based or problem-focused
trigger that necessitates evidence-based practice change (Brown, 2014). Knowledge-based
triggers occur when new research findings are produced or when there is a need for new practice
guidelines. Conversely, problem-based triggers involve the identification of clinical problems or
arise from risk management information and financial data (White & Spruce, 2015). It has been
documented that nonadherence to psychotropic medications is a major problem in the United
States, with significant impacts on patients, their families, and the health industry in general
(Steinkamp et al., 2019). In this stage, the team determines whether the target problem is a
priority. As indicated by White and Spruce (2015), organizations are more likely to prioritize
problems with higher costs or those that are voluminous.
The second step in the model involves the formation of a team to develop, implement,
and evaluate evidence-based practice change. According to Lloyd, D’errico, and Bristol (2016),
the composition of the team is dependent on the problem and should preferably include
interdisciplinary stakeholders. The team should be interested and preferably include internal and
external stakeholders.
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The third step involves collecting and analyzing research related to the identified problem
and practice change (White & Spruce, 2015). This stage includes the formation of appropriate
research questions and searching for literature on related studies. In addition, the investigator is
required to collect and review existing studies on the target clinical problem.
The fourth stage involves the critiquing and synthesis of evidence gathered during the
literature search (White & Spruce, 2015). In this step, the team reviews the collected research to
critically appraise the evidence. The appraisal process is aimed at determining whether there is
adequate high-quality evidence to address the research questions.
The fifth step involves the synthesis of evidence and making recommendations for
clinical practice (Brown, 2014). If there is adequate evidence, the change is implemented.
The sixth step involves the implementation of the systematic review after approval and
ensuring that all the procedures and policies are consistent with organizational guidelines (Lloyd
et al., 2016). The establishment of an effective communication plan for disseminating the
findings is essential. The findings can be disseminated using posters, manuscripts, and
presentations in conferences and workshops.
The final step involves evaluating whether the change is feasible and if the results can
improve patient outcomes (Lloyd et al., 2016). The evaluation phase yields feedback on the
systematic review that allows for revisions if needed. The selected studies were evaluated to
determine whether there was adequate high-quality evidence on evidence-based strategies for
improving adherence among SPMI patients.
The Iowa models provided clear frameworks for performing the systematic review. The
Iowa model also provided a systematic process of applying evidence-based literature into
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practice. Medication nonadherence among individuals with SPMI is a major problem in the
United States that needs to be addressed to improve health outcomes and minimize health care
expenditure on this population. Conducting a systematic review is a positive step in identifying
effective evidence-based strategies for improving medication adherence among SPMI patients.
Figure 1 provides the conceptual framework based on the Iowa model.
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Figure 1. The Iowa Model for Evidence-Based Practice. Source. Titler et al. (2001).
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Key Terms
Medication adherence: Medication adherence involves the extent to which an
individual’s behavior corresponds with care providers’ recommendations and prescriptions
McQuaid & Landier, 2018).
Systematic review: A systematic review is a study that summarizes the findings of
existing healthcare research that provides highly reliable evidence on the effectiveness of
specific strategies or interventions (Robinson & Lowe, 2015).
Antipsychotic: Antipsychotic medications are treatments for addressing delusions,
hallucinations, and manic symptoms in the short-term (Martino, Karnik, Osland, Barnes, &
Pringsheim, 2018).
Evidence-based interventions: Evidence-based interventions refer to peer-reviewed
strategies, programs, or practices that are published in the empirical literature of effectiveness
(Hailemariam et al., 2019).
Serious and persistent, mentally ill. SPMI comprises severe mental health disorders,
including schizophrenia, bipolar disorder, borderline personality disorder, and major depression
(Kinter, 2017).
Relevance to Nursing Practice
There is an increase in the rate of nonadherence among individuals with SPMI in the
United States (Torres-Robles et al., 2018). Mental health disorders affect over 46 million adult
Americans annually (National Institute of Mental Health [NIMH], 2019). Although psychotropic
medications are the primary form of treatment used for preventing relapse and severe
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deterioration among psychiatric patients, nonadherence is still prevalent in this population
(Torres-Robles et al., 2018).
Nonadherence to psychotropic medications has been linked to various factors, including
socioeconomic status, stigma, substance abuse disorder, care fragmentation, cultural influences,
psychopathology, issues relating to treatment, and lack of awareness (Phan, 2016; Steinkamp et
al., 2019). The growing prevalence of nonadherence among individuals with SPMI results in
increased financial burden on healthcare institutions, families, and the society in general (Joe &
Lee, 2016; Rao et al., 2017). In addition, various studies indicate that noncompliance with
prescribed psychotropic medications is a significant driver of suboptimal health outcomes among
individuals with mental health issues (Borba et al., 2018; Cutler et al., 2018; Steinkamp et al.,
2019). As indicated by Jawad et al., (2018), nonadherence to psychotropic medications can have
significant negative impacts on patients because it can cause suicidal tendencies, relapse, delayed
remission, and readmission.
The purpose of psychotropic medications among individuals with SPMI is to manage
symptoms and reduce the risk of relapse, suicidal tendencies, readmission, and longer remission
times (Borba et al., 2018). Implementing interventions that aid in promoting medication
adherence among individuals with SPMI can positively impact health outcomes and the society.
Lack of knowledge and insight of evidence-based strategies for improving adherence to
psychotropic medications has been identified as a major contributor of nonadherence (Phan,
2016). Studies have suggested various behavioral and psychoeducational interventions for
minimizing the prevalence of nonadherence among individuals with SPMI (Borba et al., 2018;
Steinkamp et al., 2019). Conducting a systematic review would improve health practitioners’
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knowledge of evidence-based strategies for improving medication adherence among individuals
with SPMI. Increase in clinicians’ knowledge and understanding of these interventions could
translate into improved patient outcomes.
Current State of Adherence to Psychotropic Medication
Nonadherence to psychotropic medications continues to be a significant problem among
adult Americans who have SPMI; thus, clinicians need to apply their expertise to identify and
design effective interventions to address the problem (Semahegn et al., 2018). This systematic
review investigated effective evidence-based strategies that can be implemented to increase
adherence to psychotropic medication among individuals with SPMI. The systematic review has
the potential to improve psychiatric clinicians’ awareness of the most appropriate and effective
interventions for improving adherence to psychotropic medications among patients with SPMI.
The systematic review facilitated the synthesis of the knowledge from the latest and most
relevant peer-reviewed evidence. An increase in awareness of evidence-based strategies for
improving adherence can be translated into practice to help improve clinical outcomes among
patients with SPMI. Consequently, an increase in adherence to psychotropic medications would
reduce the likelihood of readmission and minimize healthcare costs; thus, decreasing the
financial burden of this population. The standard practice for addressing nonadherence to
psychotropic medication involves designing a treatment plan that is consistent with the patients’
rehabilitation and recovery (Galletly et al., 2016). Over the past three decades, new psychotropic
drugs have been consistently supplied to clinicians to treat the various mental health disorders
(Lister, 2016). The U.S. Food and Drug Administration has approved nine antidepressant agents,
two classes of psychotropic drugs, and five antipsychotic medications since 1988 (Soria Saucedo
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et al., 2018). Recent empirical evidence indicates the effectiveness of various interventions in
improving medication adherence rates among adult patients with mental health issues
(Steinkamp et al., 2019). For instance, a recent study by Hughes, Vess, and Johnson (2018)
demonstrated the effectiveness of motivational adherence therapy in improving adherence to
psychotropic medications among veterans living with severe mental illnesses. After
implementing Motivational Interviewing Style Adherence Therapy (MISAT), Hughes et al.
(2018) found a clinically significant improvement in the participants’ adherence to psychotropic
medications. In addition, there was an increase in the participants' average refill history by 3%
(Hughes et al., 2018).
A study by Trujillo (2015) also indicated that mobile reminder applications and coaching
sessions could effectively increase adherence to psychotropic medication among adult patients
with SPMI. The study included 15 participants and indicated a significant increase in the
participants’ medication adherence rates after two months. A similar study by Spoelstra,
Schueller, Hilton, and Ridenour (2015) also supported the effectiveness of cognitive-behavioral
interventions and motivational interviewing in improving adherence to psychotropic
medications. Spoelstra et al. (2015) concluded that a combination of motivational interviewing
and cognitive-behavioral interventions could effectively improve medication adherence among
patients with SPMI.
Though the nonadherence rate among mental health patients differed nationwide because
of varying definitions and measurements, it is estimated that about 13-56% of all individuals
with psychiatric illnesses do not comply with prescribed medication regimen (De Las Cuevas, de
Leon, Peñate, & Betancort, 2017). The level of nonadherence among patients with different

22
mental health illness has been found to vary based on the condition. For example, the rate of
nonadherence among schizophrenia patients is approximately 50-61%, while for those with
bipolar disorder, the noncompliance rate varies from 20-60% (De Las Cuevas et al., 2017).
Nonadherence to Psychotropic Medications
Nonadherence to psychotropic medications is a significant predictor of adverse health
outcomes for mental health patients, including rehospitalization, suicide, relapse, premature
death, delays in remission, and aggression (Steinkamp et al., 2019). In addition, the positive
association has been found between nonadherence to psychotropic medications and healthcare
costs for mental health disorders with higher noncompliance rates causing higher treatment costs
(Cutler et al., 2018). The availability of psychotropic medications has improved with drugs
playing a significant role in the treatment of patients with severe psychiatric illness (Smith et al.,
2017).
Effective management of mental health disorders involves various complex medication
regimens that require a daily intake of multiple drug combinations (Smith et al., 2017). The high
rate of nonadherence to psychotropic medications among adults is associated with various
patient, systemic, and environmental factors (Gebeyehu et al., 2019). However, no factor can
thoroughly explain the reasons for nonadherence among adult patients with SPMI. For example,
older adults with mental health issues are predisposed to medication nonadherence by deficits in
cognitive processes, which impair their ability to plan and manage the intake of psychotropic
drugs effectively (Smith et al., 2017). Other reasons for nonadherence to psychotropic
medications include poor insight, stigma, distressing side effects, negative attitudes towards
medication, and ineffective therapeutic alliance (Velligan et al., 2017).
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In a recent study, Novick et al. (2015) found that increased baseline insight and an
improved therapeutic alliance was associated with higher adherence to psychotropic medications.
Therapeutic alliance involves the partnership and cooperation between mental health patients and
healthcare professionals to achieve improved outcomes (Novick et al., 2015). Conversely, insight
involves individuals’ awareness of their psychological condition (Novick et al., 2015). Insight
The primary goal of the study was to evaluate the relationship between medication adherence
and medication insight among 903 schizophrenic adult patients. The study was observational and
set in Europe, focusing on adherence to oral olanzapine medication over 12-months. The
participants used the Scale to Assess Unawareness of Mental Disorder, Global Assessment of
Functioning, Working Alliance of Functioning, Working Alliance Inventory, Medication
Adherence Rating Scale, and Clinical Global Impression. The results indicated that patients with
schizophrenia had a significantly lower insight and higher unawareness compared to those with
bipolar disorder (p < 0.001). The authors also found a significant association between higher
adherence to psychotropic medications and improved insight (p < 0.0001). Besides, there was a
strong relationship between a stronger therapeutic alliance and higher insight (p< 0.0001).
Novick et al. (2015) concluded that insight has a significant-close relationship with adherence to
psychotropic medication.
A recent systematic review by Smith et al. (2017) explored the association between
nonadherence with various domains among individuals with cognitive impairment and dementia.
The authors indicated that the adherence rates in most of the studies ranged from 10.7% to 38%,
with individuals not suffering from cognitive impairment having better compliance rates.
However, the results indicated an inconsistent variation in the definitions of adherence. Smith et
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al. highlighted that executive functioning, memory, and new learning was linked to improved
adherence to psychotropic medications. The authors concluded that there is a gap in knowledge
of some domains may contribute to medication nonadherence among mental health patients with
SPMI.
Strategies for Improving Medication Adherence
Investigators have designed various interventions that can be implemented to improve
adherence to psychotropic medications. For example, El-Mallakh and Findlay conducted a
review to evaluate interventions, notably support service, employed by clinicians to improve
medication adherence among schizophrenia patients. The study involved a comprehensive
review of the literature published over ten years period from CINAHL, Medline, PubMed
databases. The key terms used in the study included “support services,” “medication adherence,”
and “schizophrenia.” Based on the findings, 22 studies focused on support-service strategies,
including financial incentives, adherence therapy, cognitive-behavioral and motivational
strategies, and technological interventions such as the use of electronic reminders through
telephones or text messages. El-Mallakh and Findlay indicated that interventions involving
support services should be adapted to address the specific needs of patients with schizophrenia.
In addition, El-Mallakh and Findlay recommended further investigation of effective supportservice interventions that can be applied to enhance long-term medication adherence among
patients with mental illness.
Moran and Priebe (2016) also conducted a randomized controlled trial to evaluate how
financial incentives influence the intake of psychotropic medications. The study involved a
comparison of patients who were provided with financial incentives varying from £75 to £735, to
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encourage intake of antipsychotic medications and a control group who received no incentives.
Compared to the control, the intervention group demonstrated improved adherence and better
quality of life. There was an estimated 19.59 % (SD = 17, 52 %) average increase in the
participants’ adherence to antipsychotic medications. The regression model indicated that
improvement in adherence to psychotropic medications significantly predicted increased
subjective quality of life (p < 0.014). Moran and Priebe concluded that adherence to antipsychotropic medication is associated with improved quality of life; thus, the need for clinical
relevance for improved adherence resulting from financial incentives.
Kondo et al. (2015) also conducted a qualitative study exploring interventions aimed at
improving adherence to pharmacological medications among patients with bipolar disorder,
psychotic spectrum disorders, and posttraumatic stress disorder. The authors indicated that there
are various interventions for improving pharmacological adherence and are focused on patients,
providers, ad organizations. Patient-targeted interventions are mainly behavioral and
psychosocial and may include motivational interviewing, cognitive-behavioral therapy,
customized adherence enhancement, shared decision-making, and adherence and compliance
therapies. Conversely, provider-targeted interventions include training and education on
motivational interviewing. Organizational level interventions include financial incentives, care
coordination, blister packaging, and minimizing economic barriers through cost-sharing. Other
organizational level interventions for improving medication adherence include communication
technologies such as short message service (SMS), refill reminders, and e-monitoring.
Kreyenbuhl, Record, and Palmer-Bacon (2016) conducted a study to evaluate the
behavioral tailoring interventions that are used to improve medication adherence among patients
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with severe mental disorders. Kreyenbuhl, et al. identified the need for effective behavioral
interventions for improving adherence to help 60% of patients who do not take medications as
prescribed. Some of the non-technology-based behavioral interventions included environmental
supports in the individuals’ homes such as Cognitive adaptation training (CAT), pharmacy-based
and telephone reminders, and financial incentives (Kreyenbuhl et al. 2016). Conversely,
technology-based behavioral interventions for improving adherence included computerized
relational agents and electronic medication monitors.
Pauly et al. (2015) conducted a prospective clinical trial to evaluate the effects of an
inter-sectoral and multi-dimensional intervention on medication adherence among patients with
mental illnesses. The multi-dimensional component in the intervention included individualized
patient education and therapy simplification, while the inter-sectoral aspect involved subsequent
phone calls post-discharge. The study involved 269 patients from a hospital setting in Germany,
who were grouped into control and intervention groups. The authors measured the participants’
adherence using the Drug Attitude Inventory (DAI) and the Medication Adherence Report Scale
(MARS). The MARS and DAI were used to measure the participants’ adherence and attitudes
towards drugs, respectively. The results indicated an increase in the patients’ MARS and DAI
scores three months post-discharge by 1.33 and 1.93 points, respectively. Pauly et al. concluded
that inter-sectoral and multi-dimensional interventions could significantly increase medication
adherence among patients with mental health issues.
Steinkemp et al. (2019) also conducted an extensive systematic review to evaluate the
technological interventions employed by clinicians to improve medication adherence among
adults with mental health issues (Steinkamp et al., 2019). Relevant peer-reviewed articles from
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the Cochrane Central Register of Controlled Trials, MEDLINE, PsycINFO, EMBASE, Web of
Science, ClinicalTrials.gov, and Engineering Village were critically appraised to provide reliable
evidence for the study. The findings indicated that most technological interventions involve the
integration of reminders, data feedback, contingency management, support messages, care team
contact abilities, secure medication storage, psychoeducation, and social support engagement
(Steinkamp et al., 2019). The authors found that the main strategies for measuring adherence
include remote direct visualization, pill counts, biosensors, self-reports, automated compute
algorithms, ingestible sensors, and utilization measures. The intervention modalities applied
include mobile phone apps, interactive voice response, SMS, and websites (Steinkamp et al.,
2019). The authors concluded that the majority of technology-based interventions for monitoring
and improving medication adherence among mental health patients could also be applied to other
disorders.
A recent focus group by Blixen et al. (2018) evaluated how participation in a tailored
mental health intervention influences medication adherence among patients with hypertension
and bipolar disorder. The study involved 13 participants and focused on the facilitators and
perceived barriers of adherence to bipolar disorder and hypertension adherence and feedback
relating to the use of a bidirectional SMS system for medication reminders. The results indicated
that the most common barrier to medication adherence was mood fluctuations. The participants’
feedback on the effectiveness of the SMS system in improving medication adherence for bipolar
disorder was positive. Blixen et al. concluded that the implementation of mental health could
significantly improve medication adherence among patients with mental health disorders.
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Local Background and Context
The current project was focused on the Stats of Texas. According to the National
Alliance on Mental Illness (NAMI; 2019), about 19%, representing one in five, adult Americans
experienced at least one psychiatric illness in 2018. Of this population, about 4.6% experienced
severe mental illnesses. Statistics also indicate that approximately 3.7% of adult Americans
experience co-occurring psychiatric disorders annually (NAMI, 2019). The adult population
affected by mental health disorders in Texas is relatively consistent with the national prevalence,
with over 5 million Texas having mental health illnesses, which necessitate appropriate
psychotropic medications (Mental Health Texas, 2019). Of this figure, approximately 2 million
have persistent or severe psychiatric disorders such as major depression, bipolar disorder, and
schizophrenia (Mental Health Texas, 2019).
Psychiatric disorders account for approximately 14% of the disease burden and have
significantly increased over the past decade (Torres-Robles et al., 2018). In the United States,
over 46.6 million adults aged 18 years and over have a mental health issue (NIMH, 2019). This
population depends on psychotropic medications and therapy to manage their conditions and
achieve improved health outcomes and quality of life (Borba et al., 2018). However, the
uncertainty surrounding the adherence to psychotropic medications has led to mixed results on
the effectiveness of treatment (Torres-Robles et al., 2018). Studies indicate that mental health
patients can only get full benefits of psychotropic medications if they reasonably adhere to the
prescribed treatment regimens and therapy (Borba et al., 2018). The World Health Organization
(WHO) estimates that only half of patients with chronic conditions adhere to recommended
treatment regimens in developed countries (Addo, Sencherey, & Babayara, 2018). In the United
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States, the rate of nonadherence to psychotropic medications among patients with mental health
is approximately 70% (Chakrabarti, 2016). However, some researchers provide varying
estimates because of the different data collection and measurement methods (Velligan, Sajatovic,
Hatch, Kramata, & Docherty, 2017).
Statistics indicate that the cost of nonadherence per patient ranges between $3,252 and
$19,363 (Cutler et al., 2018). With approximately 46.6 million American adults who have mental
illness annually, there is a need for effective interventions to address nonadherence among this
population (NIMH, 2019). As highlighted by Kleinsinger (2018), there is a gap in the literature
on the improvement of medication adherence among mental health patients. The systematic
review addressed this gap by exploring the evidence-based strategies that can enhance mental
health patients’ adherence to psychiatric medications and regimens.
Medication nonadherence is a crucial barrier to positive health outcomes among patients
with mental health disorders, including schizophrenia, depression, and bipolar disorders (Borba
et al., 2018; Cutler et al., 2018). Various studies have indicated that suboptimal adherence to
psychotropic medications can lead to relapse, low life satisfaction, increased suicidal tendencies,
poor mental functioning, more rehospitalizations, and increased visits to the emergency
department (Cutler et al., 2018; Steinkamp et al., 2019; Velligan et al., 2017). However, there is
a high rate of nonadherence to psychotropic medications in the United States, with statistics
varying from 10-77% (Cutler et al., 2018). Some researchers have also established that
nonadherence to psychotropic medication is caused by limited awareness or insight, short illness
duration, negative attitudes towards medications, substance abuse, lack of family support, and
poor therapeutic alliances (Jawad et al., 2018). Approximately 75-90% of mental health patients
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who are discharged relapse and are readmitted (Donisi, Tedeschi, Wahlbeck, Haaramo, &
Amaddeo, 2016). Other factors that have been linked to suboptimal adherence to psychotropic
medications include reduced medication efficacy, personality traits, prescribers’ characteristics,
medication unavailability, long home-hospital distance, spirituality, preference for alternative
and complementary medications, adverse drug reactions, and displeasure with treatment (Borba
et al., 2018; Iseselo & Ambikile, 2017).
Because of the high rate of nonadherence to psychotropic medications among mental
health patients and severe consequences, various interventions have been introduced and
implemented to help address this problem (Martin et al., 2018). Medication adherence
interventions for individuals with psychiatric disorders include and not limited to cognitive
behavioral therapy, adherence and compliance therapies, technological interventions, behavioral
and psychosocial strategies, and shared decision-making (D’Rozario, Galgut, & Bartlett, 2016).
Interventions focusing on clinicians and family members have also been found to be effective in
improving adherence to psychotropic medications among individuals with psychiatric disorders
(El-Mallakh & Findlay, 2015). Medication adherence interventions targeting psychiatric
clinicians include training and education on motivational interviewing (Dobber et al., 2018).
Conversely, interventions targeted at the psychiatric facilities include financial incentives,
installation of electronic reminder systems, phone follow-up, communication technology
strategies, adoption of e-Health, and reducing potential economic barriers (WHO, 2019).
Adherence to psychotropic medication is dependent on various factors, which are mainly
related to the patients’ environment, community setting, socioeconomic status, medications, and
specific disorders. For instance, patients with high socioeconomic status are likely to be more
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adherent to psychotropic medication compared to those who live below the federal poverty
threshold (Miasso et al., 2016). African Americans and Latinos have also been found to have
lower adherence to psychotropic mediations compared to their White counterparts (Lê Cook et
al., 2017). In addition, patients with major psychiatric conditions have a higher likelihood of
nonadherence compared to those with less severe disorders (Semahegn et al., 2018). Homeless
patients and those without insurance coverage also have a high risk of nonadherence to
psychotropic medications (Rezansoff, Moniruzzaman, Fazel, Procyshyn, & Somers, 2016). The
prevailing regulatory environment also plays a significant role in promoting adherence among
patients with SPMI. Some states have adopted aggressive regulations such as Kendra’s Law in
New York State, which allows for mandatory treatment of SPMI; thus, improving adherence
rates. California and Michigan also have similar laws in “Laura’s Law” and “Kevin’s Law,”
respectively that facilitate a form of assisted outpatient treatment for individuals with mental
health issues (Swartz, Bhattacharya, Robertson, & Swanson, 2017). Under these preventive
outpatient commitment laws, mental health patients can be ordered to involuntary outpatient civil
commitment (OPC). This is if their conditions (a) would worsen if not treated, (b) impaired their
ability to adhere to treatment regimens, or (c) increase the risk of physical harm to themselves
and others if not treated (Saya et al., 2019).
Role of the DNP Student
There has been an increase in the rate of nonadherence to psychotropic medication
among patients with mental health disorders over the past few decades (Torres-Robles et al.,
2018). For this systematic review, I conducted a comprehensive systematic review of the
literature on evidence-based practices for improving adherence to psychotropic medications
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among adults with mental disorders. As the DNP student, I was tasked with performing all the
phases of the systematic review. In addition to seeking approval from Walden University’s
institutional review board (IRB), I developed a literature search plan to collect relevant primary
studies on effective evidence-based strategies for promoting adherence to psychotropic
medications. I also conducted the literature search in reliable online databases and retrieved the
studies into a personal database. I then used the retrieved articles to synthesize relevant and
current evidence-based interventions for promoting adherence. I then provided recommendations
based on the findings and develop plans for dissemination. The motivation to pursue this
systematic review was to improve awareness of evidence-based practices for improving
medication adherence among patients SPMI.
Various aspects can cause biased consideration of the systematic review’s research
questions. Though bias is highly prevalent in published studies, their prejudices should be
carefully considered to ensure ethical design and implementation of a project (Noble & Smith,
2015). A potential bias in this systematic review may result in the subjective inclusion of studies
in the systematic review. However, this bias can be avoided by using a strict inclusion-exclusion
criterion.
Summary
The purpose of this systematic review was to explore the evidence-based strategies that
can aid in increasing medication adherence in mentally ill patients. This section has provided an
overview of the background and context of nonadherence among mental health patients, a brief
description of the Iowa Model of evidence-based practice, the relevance of the systematic review
to nursing practice, and the role of the DNP student. The Iowa Model was selected because it can
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facilitate the evaluation and translation of empirical evidence into practice in order to improve
care quality. The Iowa model of evidence-based practice facilitated the identification of problemfocused and knowledge-based triggers for nonadherence among mental health patients. In
addition, the Iowa model allowed the DNP student to determine whether the identified problem
is a priority and create a team to help in the implementation and evaluation of the systematic
review. Thus, I was able to develop research questions and conduct a comprehensive literature
search.
The HBM is used to help improve the understanding of the importance of adherence to
psychotropic medications among individuals with SPMI. The focus of the systematic review
included studies on evidence-based interventions for improving adherence to psychotropic
medications among individuals with SPMI. The HBM model also helped in synthesizing
evidence involving the individuals’ beliefs and cultural backgrounds in relation to the evidencebased strategies.
Mental health issues affect approximately 47 million adult Americans (NIMH, 2019).
Approximately two million Americans experience severe or persistent or psychiatric disorders,
including schizophrenia, major depression, and bipolar disorder (Mental Health Texas, 2019).
Medication nonadherence has been linked to various negative health outcomes, including
relapse, suicidal tendencies, and even death (Cutler et al., 2018). Nonadherence to psychotropic
medications is still a major issue affecting individuals with SPMI (Semahegn et al., 2018).
However, the implementation of system-, provider-, and patient-targeted interventions can
significantly promote adherence levels in this population (Kondo et al., 2015).
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After conducting the literature search, I critiqued and synthesized evidence from the
selected studies and determined the feasibility of the proposed change. The systematic review
has significant implications for nursing practice, especially in reducing the rate of nonadherence
and improving health outcomes. The systematic review was expected to improve the
understanding of evidence-based strategies for reducing medication nonadherence among adult
patients with mental health disorders. Reducing nonadherence to psychotropic medications can
minimize the rate of adverse health outcomes among patients with psychiatric illnesses,
including suicidal tendencies, relapse, and even death (Steinkamp et al., 2019).
The systematic review could also improve the understanding of evidence-based strategies
that can be adopted to reduce the barriers to optimal adherence to psychotropic medications,
including substance abuse disorder, cultural influences, and lack of awareness (Phan, 2016). The
systematic review has the potential to address the gap in the literature on evidence-based
interventions that can be implemented to improve adherence to psychotropic medications. I
played a significant role in the systematic review, including seeking IRB approval, data
collection, literature search and synthesis, and evaluation. I also developed various
recommendations for change in practice aimed at improving adherence to psychotropic
medications. Section 3 presents a comprehensive discussion of the methods that were used to
conduct a systematic review.
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Section 3: Collection and Analysis of Evidence
Introduction
Nonadherence to psychotropic medications has been a significant public health issue in
the United States for the past few decades (Semahegn et al., 2018). Given that mental health
disorders affect approximately 46.6 million Americans, there is a need to identify the most
effective interventions for addressing the problem of nonadherence (SAHMSA, 2017). The lack
of valid and reliable evidence regarding the most effective medication adherence interventions
for mental health patients makes it difficult for stakeholders to adopt these strategies (TorresRobles et al., 2018). The purpose of this systematic review was to explore the evidence-based
strategies that can aid in increasing medication adherence in mentally ill patients. The target
problem was the high rate of medication nonadherence among individuals with SPMI. There is
also a lack of adequate evidence of effective strategies for improving adherence among
individuals with mental health disorders. This section provides a comprehensive discussion of
the practice-focused question that guided the systematic review, sources of evidence, and the
process of analyzing and synthesizing evidence from the systematic review.
Practice-Focused Question
The number of adult Americans with mental health disorders who do not adhere to their
psychotropic medications’ regime is alarming. Previous studies have indicated that nonadherence
to psychotropic medications can cause adverse health outcomes increasing the cost of health care
and the rate of rehospitalization of mental health patients (Joe & Lee, 2016; Steinkamp et al.,
2019). There is a gap in literature relating to evidence-based strategies for promoting adherence
to psychotropic medications among adult individuals with mental health disorders (Vita &
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Barlati, 2019). This project was, therefore, aimed at conducting a systematic review of current
and relevant evidence to summarize existing evidence-based strategies for improving adherence
to psychotropic medications among adult mental health patients. The guiding practice-focused
question was, “What evidence-based strategies can be implemented by healthcare providers to
improve adherence to antipsychotics among individuals with serious and persistent mental health
issues?” The question was addressed using evidence from the systematic review of current and
relevant studies on evidence-based strategies for promoting adherence to psychotropic
medications. The approach of this project included a systematic review of recent studies on
effective evidence-based interventions for promoting adherence to psychotropic medications
among adult individuals with mental health disorders. I used reliable online databases such as
Google Scholar, PubMed, and EBSCOHost.
Sources of Evidence
The sources of evidence include journal articles from online databases, including Walden
University Library, PubMed, Cochrane Collaboration, EBSCOHost, PsychINFO, ProQuest,
Joanna Briggs Institute, and Google Scholar. For this systematic review, I focused on primary
studies relating to evidence-based strategies that are used to improve medication adherence
among patients with mental.
The literature search strategy and appraisal of collected studies facilitated the synthesis of
high-quality evidence to address the practice-focused question. As recommended by Booth
(2016), I conducted the literature search process for this systematic review in five stages: (a)
formulation of the research question, (b) collection and classification of evidence, (c) critical
appraisal, (d) evidence synthesis, and (e) presentation of limitations and recommendations.
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Step 1: Research Question
The practice-focused question was, “What evidence-based strategies can be implemented
by healthcare providers to improve adherence to antipsychotics among individuals with serious
and persistent mental health issues?” The practice-focused question is essential because it
focuses on the scope of the systematic review of evidence-based interventions for promoting
adherence to psychotropic medications among mental health patients. The systematic review had
minimal risk because it did not include human participants; thus, there was no need for
adherence to associated ethical considerations (Noble & Smith, 2015). Before conducting the
systematic review, I sought authorization from the Walden University IRB. All the ethical
concerns involving copyright were followed by appropriately citing all journal articles used in
the systematic review.
Step 2: Collection and Classification of Evidence
The second step involved the collection and categorization of collected evidence using a
comprehensive literature search strategy (Booth, 2016). The literature search strategy was
conducted transparently to ensure that the studies can be evaluated appropriately and facilitate
future reproduction (Viswanathan et al., 2018). I conducted a comprehensive literature search to
ensure the inclusion of the most relevant studies while also minimizing the likelihood of
selection bias.
The literature search involved locating previous studies conducted to evaluate evidencebased strategies for promoting adherence to psychotropic medications among adult mental health
patients. The primary keywords used in the literature search include intervention, evidencebased, nonadherence, and psychotropic medication. However, I also used various combinations
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of keywords to minimize the scope of the systematic review. I also employed Medical Subject
Headings (MeSH) to refine the literature search further. The scope of the systematic review
involved studies on evidence-based interventions for improving medication adherence among
psychiatric patients published over the past 5 years. The primary sources of literature I focused
on were peer-reviewed clinical journal articles. Despite using keywords, I found that the
literature search to yielded studies that extend beyond the scope of the systematic review and
research questions. The search was further refined using an inclusion-exclusion criterion. The
inclusion criteria included selecting only articles that (a) were published between 2015 and 2019,
(b) are peer-reviewed, (c) involve evidence-based interventions for promoting adherence to
psychotropic medications, and (d) are published in English. The exclusion criteria include the
elimination of studies that (a) were published later than 2015, (b) are not peer-reviewed, (c) do
not involve evidence-based interventions for promoting adherence to psychotropic medications,
and (d) are not published in English. The literature search strategy was applied with supervision
from experts at Walden University
The selection process first involved screening the abstracts and titles of the studies to
ensure that they met the inclusion-exclusion criteria before accessing the full texts. After reading
the titles and abstracts of the studies, I selected those sources that appeared to satisfy the
inclusion-exclusion criteria. From these studies, I identified studies that contain evidence-based
practices for improving medication adherence to psychotropic medication. I maintained accurate
documentation of relevant studies throughout the literature search process, including the total
number of results yielded by every combination of keywords and those that were excluded. The
reasons for excluding studies in the findings were also provided.
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St ep 3: Critical Appraisal
The third step involved the critiquing of every selected study to produce evidence for
addressing the research question (Booth, 2016). A critical appraisal also allowed for evaluation
of the validity and applicability of the relevant studies to practice and future research. I first
evaluated the quality of the selected primary studies. The studies were critically appraised for
credibility, validity, and reliability
Step 4: Evidence Synthesis
After critically appraising the selected primary studies, I summarized the evidence to
provide a comprehensive overview of the quality and essential findings. I focused on the
methodology, sample size, and primary findings of the studies. The evidence was arranged in the
form of universal themes from the primary findings of the selected studies.
Step 5: Presentation of Limitations and Recommendations
The final step involved a detailed presentation of the limitations of the evidence and the
recommendations. The limitations allowed stakeholders to evaluate the strengths of the evidence
while also considering potential weaknesses. Based on the findings of the review, I presented
recommendations for practice, future research, theory, and policy.
The literature search focused on peer-reviewed primary studies published over the past 5
years, between 2014 and 2019. The studies needed to involve evidence-based strategies that have
been employed to improve adherence to medications among patients with mental health
disorders. The journal articles which must be published in English were critically appraised to
synthesize the most reliable evidence on effective strategies for improving medication adherence
among psychiatric patients. I developed a few key terms in addition to utilizing Medical Subject
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Headings (MeSH) to refine the literature search. I also accessed statistics on medication
adherence from reliable websites such as the WHO, National Mental Health Association
(NMHA), the American Psychiatric Association, the NAMI, the American College of Sports
Medicine, and the SAMHSA. The systematic review was aimed at addressing the gap in the
literature on evidence-based strategies that can be adopted to increase medication adherence
among mental health patients. Conducting the systematic review provided reliable evidence on
the most effective strategies for improving medication adherence and health outcomes among
patients with SPMI.
Analysis and Synthesis
The literature search was conducted exhaustively with strict adherence to the inclusion
and exclusion criteria. I recorded the total number of articles yielded by every search
combination while also documenting studies that did not meet the inclusion criteria. The
resulting journal articles were critically evaluated to synthesize evidence supporting
interventions for promoting adherence among mental health patients with SPMI. I also aimed to
develop various recommendations based on the findings of the literature search.
The journal articles were organized and ranked using the Preferred Reporting Items for
Systematic reviews and Meta-Analyses (PRISMA) method (Selçuk, 2019). The primary
keywords included intervention, nonadherence, evidence-based, and psychotropic medication.
The literature search involved various combinations in reducing the scope and producing the
most relevant studies. Evidence collected from the selected studies were used to develop reliable
recommendations for the implementation of evidence-based strategies to improve adherence to
psychotropic medications.
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The analysis process mainly involved the documentation of the online databases, the
literature search strategy, abstraction of relevant content from selected studies, and detailed
synthesis of findings from the studies. The analysis procedures involved the evaluation of the
evidence from the selected studies in relation to their strength of evidence. The entire systemic
review followed the Iowa and HBM. The Iowa model mainly guided the translation of empirical
evidence into practice to improve medication adherence among individuals with SPMI.
Conversely, the HBM helps in improving the awareness of the perceived benefits and usefulness
of medication adherence among individuals with SPMI.
Summary
The purpose of this systematic review was to explore the evidence-based strategies that
can aid in increasing medication adherence in mentally ill patients. This section has provided a
detailed overview of the methods and procedures used to conduct a systematic review. The
practice-focused question, sources of evidence, and analysis and synthesis process have been
explicitly discussed in the section. The goal of the systematic review was to synthesize the most
relevant and current evidence on interventions for promoting adherence to psychotropic
medications among adults with mental health disorders. The findings of the systematic review
were used to provide recommendations for positive change in practice to reduce the rate of
nonadherence to psychotropic medications. Section 4 provides a comprehensive discussion of the
findings of the systematic review, together with the recommendations. I also present the
implications of the results, strengths, and limitations of the systematic review in Section 4.
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Section 4: Findings and Recommendations
Introduction
Despite the effectiveness of antipsychotics in the management of mental disorders, many
patients still fail to maintain optimal adherence (Montejo et al., 2018). It is estimated that the rate
of medication nonadherence among patients with mental health disorders could reach 70%
(Chakrabarti, 2016). Given that mental health disorders affect about 47 million Americans
annually and the high cost of managing depression, there is a need to adopt more effective
interventions to improve adherence in this population (SAHMSA, 2017). These figures highlight
the extent of nonadherence to prescribed treatment regimen aimed at managing psychotic
symptoms among patients with mental health illnesses. Harrison et al. (2019) indicated that
adherence to psychotropic medication is challenging and continues to worsen in the United
States. Nonadherence has been linked to high suicide risk, deterioration, rehospitalization, and
low quality of life (Borba et al., 2018). Thus, there is a need for psychiatric clinicians to design
and adopt more effective interventions to improve adherence to psychotropic medications in
mental health patients. The problem addressed in this systematic review was the high rate of
nonadherence among individuals with SPMI. There is also inadequate literature on the most
effective strategies for improving adherence among individuals with mental health disorders.
The purpose of this systematic review was to explore the evidence-based strategies that
can aid in increasing medication adherence in mentally ill patients. This section provides a
detailed discussion of the findings and implications of the systematic review, its strengths and
implications, and recommendations based on the findings. The sources of evidence included
PubMed, Walden University Library, Google Scholar, ProQuest, Cochrane Collaboration,
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EBSCOHost, and Joanna Briggs Institute. The systematic review was conducted using the
PRISMA strategy.
Findings and Implications
For this project I employed systematic review to examine and analyze studies conducted
between 2015 and 2019, recording a total of 15,092 journal articles, reduced to 13,540 after the
duplicates were removed. However, 110 counted for eligibility, and 102 were excluded because
they did not meet the inclusion criteria. The key terms used for the journal article search included
medication adherence, antipsychotics, and medical interventions. This DNP project did not
involve human subjects; however, it adheres to rules and regulations set forth by Walden
University and the IRB. The project, therefore, aligned with the requirements of Walden
University Manual for Systematic Review and may enhance nurses, and the organization in
promoting medication adherence.
The PRISMA flow diagram (see Figure 2) presents important information pertaining to
procedural steps that were utilized for this DNP project in terms of screening, identification,
eligibility, inclusion, and exclusion.
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Records identified through
databases
(n = 15, 092)

Additional search
Other sources
(n = 0)

Records after duplicates removed
(n = 13, 540)

Research screened
(n = 13, 540)

Research excluded
(n = 13, 430)

Full text articles eligibility
(n = 110)

Full articles
excluded
(n = 102)

Studies excluded qualitative synthesis
(n = 8)

Figure 2. PRISMA flow diagram
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Table 1
Summary Table of Analyzed Articles
Citation

Main findings

Research method

Strengths

Weakness

Blixen, C., Sajatovic,
M., Moore, D. J.,
Depp, C., Cushman,
C., Cage, J., … Levin,
J. B. (2018). Patient
participation in the
development of a
customized m-health
intervention to
improve medication
adherence in poorly
adherent individuals
with bipolar disorder
(BD) and
Hypertension (HTN).
International Journal
of Healthcare, 4(1),
25–35.

Bixen (2018) study aimed
at gathering information
that would be useful in
developing an intervention
for client identification
who did not demonstrate
medical adherence
Findings included:
Forgetfulness as the most
frequent barrier to taking
antihypertensive
medications. Decisions
about taking medications
are influenced by BD
mood fluctuations and the
burden of having to take
“too many pills” for the
illnesses. There was
positive feedback on the
use of a text-messaging
system to help with
medication adherence for
BD and HTN.
It is recommended that
prescribers should educate
patients on the importance
of adherence to psychiatric
medications as a priority
and then address adherence
to medications for medical
illnesses as a secondary
goal since PWS have
reported that stable
psychiatric symptoms are
an essential precursor to
the effective management
of medical illnesses.
Novel technologies for
improving adherence are
being developed and have
undergone preliminary
feasibility testing.
mHealth applications and
text messaging are
effective in changing
health behaviors, including
medication adherence, as
well as improving clinical
outcomes for a number of
nonpsychiatric medical
conditions. mHealth AEIs
seem helpful in people for
whom nonadherence is
unintentional, that is,
related to forgetting.

Qualitative methods
were used to obtain
information. A
purposeful sampling of
30 participants was
invited via telephone 13
focus group consented.
Focus groups of 3 – 5
were conducted
debriefings were
audiotaped and later
transcribed by an expert.
Data collected was
tranquilized by
comparing focus group
sessions discussion and
noted collected by an
observer.

The study used unique
approaches, for
example collecting
information directly
from the participants
using text messages.
Furthermore, the high
presentation of
African Americans
will be considered a
strength for the study
because they are very
scarce studies using
African Americans as
the highest number of
participants in the
given study.

There was an
indication of
weakness in the
study in terms of
age, gender, and
ethnicity. The
population was
purposefully
sampled mainly,
African American
females.

Literature review of 22
studies.

An improvement in the
positive symptom
rating subscale of the
Positive and Negative
Syndrome Scale was
the strongest predictor
of treatment
adherence, regardless
of the medication that
was prescribed.

Problems with
medication
adherence due to
financial constraints
and affordability of
medications were
not addressed in
these studies, which
is a noteworthy gap
that warrants further
research.

Systematic literature
review with metaanalysis.

Adherence-enhancing
interventions (AEIs)
utilizing the platforms
have the potential for
widespread
dissemination to a
broad range of
individuals with
serious mental illness.
Mobile phones, in
particular are relatively
low cost and have the
potential for replacing
face-to-face contact
with health care
professionals.

Experience is more
limited in mHealth
applications
involving mobile
phones and similar
technologies.
Formal economic
evaluations of
AEIs employing
these technologies
are still needed to
obtain maximum
benefit.

El-Mallakh, P., &
Findlay, J. (2015).
Strategies to improve
medication adherence
in patients with
schizophrenia: The role
of support services.
Neuropsychiatric
Disease and
Treatment, 11, 10771090.

Kreyenbuhl, J.,
Record, E. J., &
Palmer-Bacon, J.
(2016). A review of
behavioral tailoring
strategies for
improving medication
adherence in serious
mental
illness. Dialogues in
clinical
neuroscience, 18(2),
191.

Level of
Evidence
Level IV

Level V

Level I

(Table Continues)
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Citation

Main findings

Research method

Strengths

Weakness

Level of
Evidence

Montejo, A. L.,
Montejo, L., &
Baldwin, D. S. (2018).
The impact of severe
mental disorders and
psychotropic
medications on sexual
health and its
implications for
clinical
management. World
Psychiatry, 17(1), 311.

Sexual dysfunction is
common during short‐and
long‐term treatment with
antipsychotics. It is
associated with an impact
on the quality of life in
adult and adolescent
patients. Erectile problems
with antipsychotic drugs
are related to endothelial
dysfunction linked to
decreased nitric oxide
production. Depressive
symptoms are associated
with sexual difficulties and
dissatisfaction. Patients
with bipolar disorder tend
to have more stable sexual
partners and more intense
sexual activity than those
with schizophrenia.
Improvement in
medication adherence was
found to be a significant
predictor of better
subjective quality of life
whilst the amount of
incentives received was
not.
Improved medication
adherence is associated
with a more favorable
SQO.

Randomized placebocontrolled trial.

Treatments with fewer
adverse sexual effects
should be considered
as potential first‐line
options in patients with
severe mental illness
interested in
maintaining a sexual
life.

It seems difficult to
perform systematic
inquiries in all
patients about
previous and
current sexual life
needed to assess
potential sexual
dysfunction.
There is little
evidence about the
management of
sexual dysfunction
associated with
mood stabilizers.

Level I

Quality improvement.
A secondary analysis
was performed using
data of the experimental
group in the trial.
Regression models.

Use of audits to ensure
correct data is
analyzed.

There was no
analysis of data
regarding the
amount incentives
received.

Level II

Two hundred sixty-nine
patients from a German
university hospital were
included in a
prospective, open,
clinical trial with
consecutive control and
intervention groups 269
patients from a German
university hospital were
included in a
prospective, open,
clinical trial with
consecutive control and
intervention groups.

It was determined that
the implementation of
a multi-dimensional
and inter-sectoral
program enhances the
patients’ adherence
significantly up to
three months after
discharge.

A patient’s selfreport is an indirect
and subjective
approach, and thus
a less valid way of
measuring
adherence
compared to direct
methods.
Seasonal
fluctuations and
rotating physicians
influence the
patients’ behavior
and lead to a
possible over- as
well as underestimation of the
intervention’s effect
size. The study time
was too short for
measuring relapse
and subsequent
readmission to the
hospital.

Level III

Moran, K., & Priebe,
S. (2016). Better
quality of life in
patients offered
financial incentives for
taking anti-psychotic
medication: Linked to
improved adherence or
more money? Quality
of Life Research,
25(8), 1897-1902.

Pauly, A., Wolf, C.,
Mayr, A., Lenz, B.,
Kornhuber, J., &
Friedland, K. (2015).
Effect of a multidimensional and intersectoral intervention on
the adherence of
psychiatric patients.
PloS one, 10(10),
e0139302.

Adherence in psychiatric
patients is strongly
affected by their attitude
towards their medication.
Increasing age contributes
to a more adherent
behavior until a threshold
of about 75 years when
forgetfulness and frailty
impede adherence.

(Table continues)
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Citation

Main findings

Research method

Strength

Weakness

Level of
Evidence

Rolving, N., Brocki, B.
C., Mikkelsen, H. R.,
Ravn, P., BlochNielsen, J. R., & Frost,
L. (2017). Does an 8week home-based
exercise program affect
physical capacity,
quality of life, sick
leave, and use of
psychotropic drugs in
patients with
pulmonary embolism?
Study protocol for a
multicenter
randomized clinical
trial. Trials, 18(1), 245.
Steinkamp, J. M.,
Goldblatt, N.,
Borodovsky, J. T.,
LaVertu, A., Kronish,
I. M., Marsch, L. A., &
Schuman-Olivier, Z.
(2019). Technological
interventions for
medication adherence
in adult mental health
and substance use
disorders: A systematic
review. Journal of
Medical Internet
Research Mental
Health, 6(3), e12493.
doi:10.2196/12493

A home-based exercise
program improves the
physical capacity and
quality of life for the
patients in the intervention
group.

Multicenter,
randomized, controlled,
assessor-blinded,
superiority trial,
investigating the effect
of a low-cost homebased exercise program
for acute pulmonary
embolism.

The implementation
process was
interdisciplinary and
standardized.
The study time allotted
was adequate.

The
implementation
period was too
short.

Level II

Despite the differences in
the mental state between
different disorders, and
perhaps even different
primary reasons for
nonadherence, there is still
much to be learned and
transferred from one
domain to the others.
The most commonly
studied method for
measuring medication
adherence is patient selfreport
Multicomponent
interventions, including
comprehensive disease
management apps, have
been studied in the
majority of psychiatric
disorders.

A systematic scoping
review of technological
interventions designed
to improve medication
adherence in mental
health and substance use
populations
Qualitative synthesis of
themes in the literature.

The strengths of our
study included the
breadth of the topic
area and the
comprehensive
coverage of all types
of interventions, as
well as the literatureguided taxonomic
framework.
Tables of
multicomponent
interventions showed
the utility of this
transdiagnostic
framework to
decompose and
categorize
interventions across all
adult mental health and
substance use
disorders.

The study was
limited by this
breadth;
researchers were
unable to conduct
a quantitative
synthesis or
formal metaanalysis of all
included studies
given the wide
variety of
interventions,
populations, and
outcomes.

Level I

All selected articles were critically evaluated by examining each study, goals, design,
methodology, results, sample size, and conclusions. I consulted the chair to ensure reliability and
validity. All of the selected studies indicated evidence-based interventions that are employed to
improve medication adherence among individuals with mental health issues. Three studies
addressed the effectiveness of financial incentives (El-Mallakh & Findlay, 2015; Kreyenbuhl et
al., 2016; Moran & Priebe, 2016). In addition to financial incentives, Kondo et al. (2015)
evaluated other system-targeted interventions, including care coordination, blister packaging, and
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cost-sharing. Five studies addressed technological interventions for improving medication
adherence (Blixen et al., 2018; Kondo et al., 2015; Kreyenbuhl et al., 2016; Steinkamp et al.,
2019). Only two studies evaluated the effectiveness of non-technological behavioral
interventions (Kreyenbuhl et al., 2016; Pauly et al., 2015). In addition, one study addressed the
use of a home-based physical exercise program to improve medication adherence (Rolving et al.,
2017).
El-Mallakh and Findlay (2015) found that interventions that incorporate support services
should be adopted to help in addressing special needs among mental health patients. Similarly,
Kreyenbuhl et al. (2016) recommended the adoption of effective cognitive-behavioral
interventions to improve medication compliance. Moran and Priebe (2016) indicated that
improving medication compliance among mental health patients would enhance their quality of
life. Kondo et al. (2015) recommended the adoption of psychosocial and behavioral
interventions, including motivational interviewing, shared decision-making, compliance
therapies, customized adherence enhancement, and cognitive-behavioral therapy. Rolving et al.
(2017) found that physical exercise programs can improve adherence to psychotropic
medication, patients’ quality of life, and physical capacity.
Data Analysis
A descriptive statistical analysis approach was utilized to statistically analyze this
doctoral project specifically to analyze studies conducted between 2015 and 2019. Analysis of
the selected articles was conducted using quantities approaches. Initially, I read all the referenced
articles. Although all the articles had been searched with the keywords and retrieved from
professional databases, I was able to identify some studies that were generally highly
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methodological. For instance, those articles had frequent and thorough descriptions of how
patients fail to adhere to medication, never followed through with the health care providers
especially after discharge from the hospital, and while in other environments including nursing
homes, or under care and supervision of family members as well as on their own personal
setting. After that, I independently assessed the methodological quality using a systematic review
approach. For instance, in each study, I counted the number of times/frequencies of specific
parameters that included the following: mental health, medication adherence, and interventions
were mentioned. The findings of this present DNP analysis were tabulated and are presented in
the Table 2.
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Table 2
Frequencies
Articles

Hospital
Mental
health

Blixen et al.
(2018).

Nursing home

Heath
adherence

Intervention

Mental
health

Heath
adherence

✔

✔

✔

✔
✔

Family care
Intervention

Mental
health

Heath
adherence

Personal setting
Intervention

✔

Mental
health

Heath
adherence

Total
Intervention
7

✔

✔

Hartung, Low,
Jindai,
Mansoor,
Judge,
Mendelson, &
Kondo (2017).
Kreyenbuhl,
Record, &
Palmer-Bacon
(2016).
Moran & Priebe
(2016).

✔

✔

✔

✔

✔

✔

✔

✔

✔

✔

✔

Pauly, Wolf,
Mayr, Lenz,
Kornhuber, &
Friedland
(2015).
Rolving,
Brocki,
Mikkelsen,
Ravn, BlochNielsen, &
Frost,
(2017).
Steinkamp et al.
(2019).

✔

Total number
of each factor
in the
method,
results, and
discussion
sections.

✔

✔

✔

✔

✔

✔

✔

7

6

7

✔

✔

✔

✔

✔

✔

7

✔
✔

5

✔

6

4

✔
5

3

Note: Number of frequencies of the variables under investigation

2

8

6

✔

✔

✔

✔

3

2

2

2

1

1

41
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Findings
I employed both qualitative and quantitative approaches to interpreting findings. The
overall number frequencies were based on the total number of each factor that was mentioned in
the method, results, and discussion of the journal articles. In general, the total number of
frequencies was 41. The results revealed that the majority of patients could demonstrate
medication adherence as a result of interventions and could significantly affect positive
improvement in their quality of life. Four out of the eight articles yield higher frequencies
compared to other articles. Those specific articles (Blixen, et al., 2018; Kondo et al., 2017;
Kreyenbuhl et al., 2016; Rolving et al., 2017) presented thorough descriptions of factors
analyzed when compared to other studies. On the other hand, limited intervention frequencies
based on low raw scores were documented under family care and personal settings (Pauly et al.,
2015; Steinkamp, et al., 2019). Arguably, these findings indicated the need for health care staff
to establish more collaboration approaches that could support mental health patients’ medical
adherence while working with family members, or on their own.
Numerous studies regarding this study were conducted by (El-Mallakh & Findlay, 2015;
Kreyenbuhl et al., 2016; Montejo et al., 2018; Moran & Priebe, 2016; Rolving et al., 2017;
Steinkamp et al., 2019) in different settings. However, their general goal was the advocacy for
mental health patients in terms of medication adherence and innovative approaches, including
interventions that can potentially motivate mental health patients to adhere to medication and
improve their quality of life. Steinkamp et al.’s (2019) qualitative study targeted at populating a
comprehensive framework by generating themes from the literature review, and the results were
graphically presented using graphic organizers that included concept maps. The study classified
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components understudy into interventions, medication adherence, mental health, and substance
use populations. In support, Kreyenbuhl et al. (2016) pointed out the need for health care
workers to emphasize and stress medication adherence after patient discharge. Kreyenbuhl et al.
also advocated for innovative approaches such as integrating electronic technology monitors and
mobile phones to monitor and strengthen compliance policies in support of patient’s medication
adherence. Recent studies (Montejo et al., 2018.) postulate that management of mental health
treatment offsite the hospital setting is indeed crucial.
Furthermore, Rolving et al. (2017) advocated for a home care program that could vitally
enhance the physical ability and quality of life among mental health patients. Other studies
examined for this study attest that home visit programs with a well-designed schedule, providing
daily living skills training, could enable mental health patients to follow through with health care
providers and thus medication adherence (El-Mallakh & Findlay, 2015). Also, Moran and Priebe
(2016) linked good adherence to antipsychotic medication.
Unanticipated limitations/outcomes. A primary limitation of the systematic review was
the use of a single reviewer, which limited the number and rigor of the review process. The
inclusion of more reviewers would facilitate in-depth and more extensive evidence appraisal. In
addition to the time-consuming, nature of systematic review, investigators may also experience
various difficulties in combining studies when conducting systematic reviews. Another limitation
of the systematic review is that the selected studies employed different designs, thus making it
challenging to combine the findings. In addition, the review process yielded a limited sample of
studies; thus, the research goals and objectives may not have been addressed adequately.
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Implications from Findings
The findings of this systematic review have a significant impact on individuals with
mental health disorders, communities, psychiatric institutions, and the healthcare system in
general. For example, mental health patients can apply knowledge from this systematic review to
select the most effective evidence-based interventions for improving adherence to psychotropic
medications. Also, psychiatric clinicians apply the findings to design interventions that meet the
specific needs of individual mental health patients. Enhanced awareness of evidence-based
strategies for improving adherence to psychotropic medications can significantly benefit
patients’ family members and the community in general. For instance, clinicians can design
specific interventions for individual populations, depending on their needs. The current
systematic review can also be used by psychiatric institutions as a reference when designing
interventions for improving adherence to psychotropic medications.
Also, the findings have significant implications for positive social change in psychiatric
care in the United States. Increased awareness of evidence-based interventions for medication
adherence can be translated into practice to improve health outcomes among this population.
Improvement of health outcomes among mental health patients can result in a reduction in
healthcare costs and the rate of readmission.
Recommendations
Based on the comprehensive literature review, the selected articles identified various
studies that indicated the effectiveness of evidence-based interventions for improving mental
health patients’ adherence to psychotropic medications. A recommendation for psychiatric
clinicians was to address the current gap in knowledge by conducting further research on
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technological interventions for improving medication adherence among patients with mental
illnesses. In addition, more qualitative studies involving interviews or focus groups should be
conducted to understand patients’ perceptions and attitudes regarding specific evidence-based
interventions for improving adherence to psychotropic medications.
Strengths and Limitations of the Project
A primary strength of the systematic review was the use of a systematic review design,
which allowed for the usage of detailed inclusion-exclusion criteria. Systematic reviews also
facilitate a comprehensive and exhaustive study of current, ongoing, and unpublished literature
to address a given problem (Selcuk, 2019). Findings from systematic reviews can also be
generalized to broader populations; thus, it can be used as reliable and accurate sources of
evidence (Robinson & Lowe, 2015). The systematic review also employed the HBM and Iowa
models that allowed the application of concepts, including perceived self-efficacy and usefulness
of the evidence-based strategies for improving medication adherence. Another strength of this
systematic review is that the knowledge, skills, and evidence that I gained throughout the process
are transferrable into practice.
In relation to the methodologies, there is still a need for more qualitative studies to
explore mental health patients’ perceptions of the most effective evidence-based interventions
for improving adherence to psychotropic medications. An in-depth understanding of patients’
preferences, needs, and attitudes regarding specific interventions can aid in enhancing adherence
because of improved willingness. Thus, future studies need to incorporate qualitative approaches,
including face-to-face interviews, focus groups, and case studies to address the existing gap in
knowledge of evidence-based medication adherence interventions.
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Section 5: Dissemination Plan
Introduction
The current systematic review provided an opportunity for psychiatric nurses to
understand the various evidence-based interventions for improving medication adherence among
mental health patients. Thus, the dissemination of the findings can play an essential role in
addressing the knowledge gap and facilitating the translation of evidence into practice. This
section provides a comprehensive overview of how the systematic review findings were
disseminated and the analysis of self in different professional roles.
Dissemination of Findings
The primary audience for the dissemination of the systematic review includes psychiatric
clinicians, nurse managers, and adult mental health patients. A practical method for
disseminating the findings of the systematic review is the development of a manuscript that was
published in nursing journals and websites of psychiatric facilities. The manuscript can also be
presented in future conferences and workshops. I also developed a poster and PowerPoint
presentation that will be made available to psychiatric clinicians. The advantage of developing
posters and PowerPoints presentations is that they can be presented to wide audiences in open
forums. Because of the nature of the systematic review, the ideal audience is psychiatric nurses,
physicians, and associated health care providers. The potential avenue of dissemination of this
evidence-based systematic review is by conferences, workshops, and manuscripts that include
journals such as the Journal of Psychiatric Research and The American Journal of Psychiatry.
The available resources will be compiled together in a mini folder and be made available at the
clinic as well as handing them to the healthcare providers for quick reference when needed.
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Analysis of Self
My doctoral journey and the process of developing this systematic review has equipped
me with immense knowledge and skills necessary to succeed in my practice area. First, the DNP
project has strengthened me with leadership skills as a project leader and facilitator. As a project
manager, I was able to enhance my planning and resource management skills by ensuring all
project deliverables were met. I planned and executed every part of the project within the
scheduled timeframe. As a nurse practitioner, I used knowledge from the DNP program to design
the systematic review and conduct a comprehensive systematic review to identify the most
effective interventions for improving medication adherence. Nurses who work in complex
settings have the responsibility of identifying gaps in practice and designing or recommending
effective interventions.
As a scholar, the systematic review strengthened my research, data collection, and
analytical skills as I was able to access different libraries and appraised relevant studies. The
primary goal of the systematic review was to address the gap in knowledge on evidence-based
strategies for improving adherence to psychotropic medications. My educational background as a
scholar prepared me adequately for the data collection, systematic review, and evaluation
processes. One challenge I experienced was the limited number of studies evaluating the
effectiveness of specific interventions for improving adherence to psychotropic or antipsychotic
medications. There is a lack of practice guidelines regarding the implementation of evidencebased interventions for improving mental health patients’ adherence to psychotropic
medications.
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Summary
The purpose of this systematic review was to explore the evidence-based strategies that
can aid in increasing medication adherence in mentally ill patients. The target problem was the
lack of adequate evidence of effective interventions for improving mental health patients’
adherence to psychotropic medications. The systematic review yielded various interventions
focused at patients, psychiatric clinicians and family members, and other health care
professionals. The systematic review yielded eight studies that have addressed evidence-based
strategies targeted at patients, psychiatric clinicians, and systems. Specifically, the studies
addressed interventions such as financial incentives, care coordination, blister packaging, and
cost-sharing. Also, the studies evaluated technological interventions and a home-based physical
exercise program. The systematic review is an essential addition to existing evidence on effective
strategies for improving medication adherence among individuals with mental health issues.
However, there is a need for further qualitative studies to address patients’ preferences of the
most effective evidence-based interventions that meet their needs.
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